Clinical Trial Update: An Exploratory Basket Study of Pyrotinib Maleate Tablets in HER2 Mutated or Amplified of Metastatic Solid Tumors [Phase 2]

View source ↗

Summary

Phase 2 exploratory basket trial of pyrotinib maleate in HER2-mutated or amplified metastatic solid tumors; status not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• Pyrotinib maleate tablets (pyrotinib)

Snippet

Sponsor: Zhongshan Hospital Xiamen University | Conditions: Solid Tumor | Phase 2 | Status: UNKNOWN